1. Medtech Insight
  2. >>Policy & Regulation

Abbott Hopes To Prevent Heart Failure Hospitalizations With New CardioMEMS HF Labeling

 
• By Reed Miller

The FDA expanded the indication for Abbott’s CardioMEMS HF wireless heart failure monitor to include patients who have never been hospitalized for heart failure before.

Implantable Pulmonary Pressure Sensor for Abbott's CardioMEMS HF heart failure monitor • Source: Abbott

Abbott reached another major milestone in the development of its CardioMEMS HF heart failure monitor with the US Food and Drug Administration approval of expanded labeling.

CardioMEMS HF is a small implantable sensor that detects changes in pulmonary artery pressure and wirelessly communicates the data to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Policy & Regulation